Cisatracurium besylate injection is a nondepolarizing neuromuscular blocker indicated:

• as an adjunct to general anesthesia to facilitate tracheal intubation in adults and in pediatric
• patients 1 month to 12 years of age
• to provide skeletal muscle relaxation during surgery in adults and in pediatric patients 2 to 12
• years of age as a bolus or infusion maintenance
• for mechanical ventilation in the ICU in adults